The incidence of diabetic foot ulcer (DFU) is continuously increasing in elderly diabetic patients. The treatment of DFU in elderly people is often unsatisfactory due to their relatively weak immunity and the vascular lesions caused by diabetes. 1,2 Furthermore, commonly associated diseases with DFU such as infection, gangrene and other serious complications potentially lead to unavoidable amputations and other destructive consequences both the patient's physical and mental health, thereby posing serious threats to people's health. 3,4 At present, there are various clinical treatments for DFU, and many new drugs have been developed for diabetic wound repair. 5-8 However, these treatments cannot provide maximum clinical outcome for DFU, and the specific molecular mechanism of DFU development remains elusive. Exosome, an extracellular vesicle with a diameter of 30-100 nm, has a strong biological function. The vesicle contains non-coding RNA, cholesterol, protein and other bioactive substances and has been extensively proved for regulating diverse biological processes in vivo. 9,10 In this study, circulating exosomes from diabetic (Dia-Exos) and non-diabetic patients (Con-Exos) were isolated, extracted and identified, and their respective biological functions and underlying molecular mechanisms were further studied.